Solid Biosciences Inc.SLDBNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank40
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P40
Within normal range
vs 5Y Ago
-1.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-38.14%
2024-24.36%
20232.01%
2022-47.33%
202116.43%
202027.54%
2019-57.65%
2018-37.97%
2017-114.49%
2016-289.64%